Sector: MedicalOSI Pharmaceuticals Inc. (NASDAQ: OSIP)
Headlines
- OSI Pharmaceuticals to Present at the Oppenheimer 20th Annual Healthcare Conference on Tuesday, November 3, 2009
Oct 27, 2009 11:00 AM | OSIP
- The Week In Review: International Initiatives
Oct 24, 2009 01:24 PM | CMED, OSI, OSIP, SCR
- Large & Small-Cap Companies Making Big Strides In The Fight Against Cancer (CTIX.OB, LLY)
Oct 20, 2009 05:50 PM | LLY, OSIP, PFE
- Simcere Pharmaceutical Group Announces Collaboration with OSI Pharmaceuticals
Oct 20, 2009 06:01 AM | OSIP, SCR
- OSI Pharmaceuticals to Announce Third Quarter 2009 Financial Results on October 21, 2009
Oct 12, 2009 11:00 AM | OSIP
- AVEO Pharmaceuticals to Present at the JMP Securities Healthcare Focus Conference
Oct 01, 2009 08:30 AM | BIIB, LLY, MRK, OSIP, SGP
- Revolutionary Drug Could Be New Hope for Adrenal Cancer Patients
Sep 22, 2009 12:01 PM | OSIP
- U.S. Patent and Trademark Office Issues a Notice of Allowance in OSI Pharmaceuticals' Reissue Application on Tarceva(R) Composition of Matter Patent
Sep 17, 2009 01:37 PM | OSIP
- OSI Pharmaceuticals to Present at the Morgan Stanley Healthcare Conference on Tuesday, September 15, 2009
Sep 08, 2009 11:25 AM | MS, OSIP
- InvestorSoup.com Issues Technical Trading Outlook for Cell Therapeutics Inc.
Sep 08, 2009 06:54 AM | BMY, CTIC, NVS, OSIP
- Movers: Wells Fargo, Wachovia, Citigroup, ImClone, eBay
Oct 07, 2008 10:55 AM | BAC, BMY, C, DNA, EBAY, HIG
- OSI Pharmaceuticals, Inc. Announces Third Quarter 2009 Financial Results
Oct 21, 2009 04:51 PM | OSIP
- New Data from Phase III SATURN Study Showed Tarceva Extended Survival in Patients with Advanced Non-Small Cell Lung Cancer When Used Immediately after Initial Chemotherapy
Aug 01, 2009 01:01 PM | OSIP
- OSI Pharmaceuticals to Present at the BMO Capital Markets 9th Annual Focus on Healthcare Conference on Wednesday, August 5, 2009
Jul 29, 2009 01:10 PM | OSIP
- Hercules Technology Growth Capital Announces Successful Fund Raising Activities From Select Life Sciences Portfolio Companies Despite Challenging Economy
Jul 27, 2009 09:59 AM | HTGC, MRK, OSIP
- StockPreacher.com Issues Trading Outlook for Onyx Pharmaceuticals Inc. (ONXX)
Jul 27, 2009 06:51 AM | AMGN, ONXX, OSIP, PFE, SGEN
- OSI Pharmaceuticals, Inc. Announces Second Quarter 2009 Financial Results
Jul 22, 2009 04:54 PM | OSIP
- OSI Pharmaceuticals and AVEO Pharmaceuticals Expand Oncology Discovery and Translational Research Collaboration
Jul 21, 2009 07:32 AM | OSIP
- New Data from Phase III SATURN Study Showed Tarceva Improved Overall Survival When Used Immediately After Initial Chemotherapy in Patients with Advanced Non-Small Cell Lung Cancer
Jul 13, 2009 01:01 AM | OSIP
- OSI Pharmaceuticals to Announce Second Quarter 2009 Financial Results on July 22, 2009
Jul 08, 2009 10:48 AM | OSIP
- OSI Pharmaceuticals Announces Consolidation of U.S. Operations
Jul 07, 2009 04:05 PM | OSIP
- Form 3 Rachman Jonathan For: Sep 01 (10K)
Sep 09, 2009 11:01 AM
- Form 4 WOOD BARBARA A For: Jul 14 (10K)
Jul 16, 2009 04:44 PM
- Form 4 LEUNG GABRIEL For: Jul 14 (10K)
Jul 16, 2009 04:36 PM
- Form 4 SIMON ROBERT L For: Jul 14 (10K)
Jul 16, 2009 04:33 PM
- Form 4 WHITE JOHN P For: Jun 17 (10K)
Jun 19, 2009 11:39 AM
- Form 4 OSI PHARMACEUTICALS INC For: Jun 17 Filed by: STEVENSON KATHARINE BERGHUIS (10K)
Jun 19, 2009 11:36 AM
- Form 4 PINEDO HERBERT MD PHD For: Jun 17 (10K)
Jun 19, 2009 11:35 AM
- Form 4 NIEMIEC DAVID W For: Jun 17 (10K)
Jun 19, 2009 11:32 AM
- Form 4 MEHTA VIREN For: Jun 17 (10K)
Jun 19, 2009 11:32 AM
- Form 4 LEE KENNETH B JR For: Jun 17 (10K)
Jun 19, 2009 11:30 AM
Analyst Ratings
Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
Share Performance
|
Period
|
OSIP
|
Compare to S&P
|
| YTD |
-17.49 %
|
-28.08 %
|
| 4 Weeks |
-5.68 %
|
-6.68 %
|
| 12 Weeks |
-2.04 %
|
-4.47 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: 178.57 %
|
|
EPS Growth in Last Year: 39.29 %
|
|
Sales Growth in Last Quarter: 12.50 %
|
|
Sales Growth in Last Quarter: 17.84 %
|
|
